These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34986140)

  • 1. Evolutionary plasticity and functional versatility of CRISPR systems.
    Koonin EV; Makarova KS
    PLoS Biol; 2022 Jan; 20(1):e3001481. PubMed ID: 34986140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In defense of phage: viral suppressors of CRISPR-mediated adaptive immunity in bacteria.
    Wiedenheft B
    RNA Biol; 2013 May; 10(5):886-90. PubMed ID: 23392292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas systems: beyond adaptive immunity.
    Westra ER; Buckling A; Fineran PC
    Nat Rev Microbiol; 2014 May; 12(5):317-26. PubMed ID: 24704746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unravelling the structural and mechanistic basis of CRISPR-Cas systems.
    van der Oost J; Westra ER; Jackson RN; Wiedenheft B
    Nat Rev Microbiol; 2014 Jul; 12(7):479-92. PubMed ID: 24909109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas: evolution of an RNA-based adaptive immunity system in prokaryotes.
    Koonin EV; Makarova KS
    RNA Biol; 2013 May; 10(5):679-86. PubMed ID: 23439366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobile Genetic Elements and Evolution of CRISPR-Cas Systems: All the Way There and Back.
    Koonin EV; Makarova KS
    Genome Biol Evol; 2017 Oct; 9(10):2812-2825. PubMed ID: 28985291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral diversity threshold for adaptive immunity in prokaryotes.
    Weinberger AD; Wolf YI; Lobkovsky AE; Gilmore MS; Koonin EV
    mBio; 2012 Dec; 3(6):e00456-12. PubMed ID: 23221803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation.
    Bhaya D; Davison M; Barrangou R
    Annu Rev Genet; 2011; 45():273-97. PubMed ID: 22060043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas in mobile genetic elements: counter-defence and beyond.
    Faure G; Shmakov SA; Yan WX; Cheng DR; Scott DA; Peters JE; Makarova KS; Koonin EV
    Nat Rev Microbiol; 2019 Aug; 17(8):513-525. PubMed ID: 31165781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas: Complex Functional Networks and Multiple Roles beyond Adaptive Immunity.
    Faure G; Makarova KS; Koonin EV
    J Mol Biol; 2019 Jan; 431(1):3-20. PubMed ID: 30193985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea.
    Marraffini LA; Sontheimer EJ
    Nat Rev Genet; 2010 Mar; 11(3):181-90. PubMed ID: 20125085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clustered regularly interspaced short palindromic repeats (CRISPRs): the hallmark of an ingenious antiviral defense mechanism in prokaryotes.
    Al-Attar S; Westra ER; van der Oost J; Brouns SJ
    Biol Chem; 2011 Apr; 392(4):277-89. PubMed ID: 21294681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type IV CRISPR-Cas systems are highly diverse and involved in competition between plasmids.
    Pinilla-Redondo R; Mayo-Muñoz D; Russel J; Garrett RA; Randau L; Sørensen SJ; Shah SA
    Nucleic Acids Res; 2020 Feb; 48(4):2000-2012. PubMed ID: 31879772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems.
    Hwang S; Maxwell KL
    CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of CRISPR-Cas Type III prokaryotic defence systems.
    Molina R; Sofos N; Montoya G
    Curr Opin Struct Biol; 2020 Dec; 65():119-129. PubMed ID: 32712502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live virus-free or die: coupling of antivirus immunity and programmed suicide or dormancy in prokaryotes.
    Makarova KS; Anantharaman V; Aravind L; Koonin EV
    Biol Direct; 2012 Nov; 7():40. PubMed ID: 23151069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-mediated adaptive immune systems in bacteria and archaea.
    Sorek R; Lawrence CM; Wiedenheft B
    Annu Rev Biochem; 2013; 82():237-66. PubMed ID: 23495939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unprecedented Diversity of Unique CRISPR-Cas-Related Systems and Cas1 Homologs in Asgard Archaea.
    Makarova KS; Wolf YI; Shmakov SA; Liu Y; Li M; Koonin EV
    CRISPR J; 2020 Jun; 3(3):156-163. PubMed ID: 33555973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CRISPR-Cas Mechanism for Adaptive Immunity and Alternate Bacterial Functions Fuels Diverse Biotechnologies.
    Newsom S; Parameshwaran HP; Martin L; Rajan R
    Front Cell Infect Microbiol; 2020; 10():619763. PubMed ID: 33585286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolutionary Genomics of Defense Systems in Archaea and Bacteria.
    Koonin EV; Makarova KS; Wolf YI
    Annu Rev Microbiol; 2017 Sep; 71():233-261. PubMed ID: 28657885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.